Brinton gets DCGI approval ; Faviton (Favipiravir) 400 mg ; Rs 79 per tablet

▴ faviton-favipiravir-400-mg-rs-79-per-tablet-brinton-pharma
Brinton Pharma makes Covid treatment manageable by launching 400 mg tablets at Rs 79

Brinton Pharmaceuticals on Thursday reported to received approval from the Drugs Controller General of India to launch Favipiravir 400 mg tablets under the brand name Faviton for Rs 79 per tablet. The tablets are indicated for the treatment of patients with mild to moderate COVID-19 symptoms, Brinton Pharmaceuticals said in a statement.

Under the current treatment regimen with Favipiravir 200 mg tablets, patients have to take 18 tablets on day one, and followed by 8 tablets for next 10-14 days, it added. With the launch of Faviton 400 mg, the number of tablets to be consumed have reduced to half, the statement said.

The tablets will be available across all COVID-19 treatment centres at Rs 79 per tablet, the statement said. "With the launch of Faviton 400mg, the pill burden of the patients will be reduced. It will also offer dosing convenience which will improve the patients' compliance and clinical outcome," Brinton Pharmaceuticals MD Rahul Kumar Darda said.

The company's intent will be to improve the access through its strong distribution network that will help make Faviton 400mg available across all COVID-19 treatment centres, he added.

Brinton is one of the fastest growing Indian Global Pharmaceutical Company spreading its network worldwide.Brinton has a rich and ever-evolving portfolio, state-of-the-art resources in R&D, manufacturing, marketing and sales that assure to deliver value to its customers satisfy unmet medical needs and improve their lives.

Brinton has a tie up with leading manufacturing plants which are certified with all major accreditations such as US FDA, UK MHRA, WHO, GMP, ANBISA - Brazil, Ukraine, Pharmacy and Poison Board Of Kenya, NAFDAC. Nigeria, Ministry of Health Yemen, Ministry of Health Congo, IDA Netherlands & Spanish Agency of Medicines and Health Care Products.

Tags : #BrintonPharma #RahulDarda #Favipiravir400mg #FavipiravirFaviton #CoronavirusDrug #Favipiravirprice #FavitonPrice

About the Author

Team Medicircle

Related Stories

Loading Please wait...


Trending Now

Serum Institute of India Partners with Oxford University to Develop Meningitis-B VaccineApril 18, 2024
Ethical Concerns Arise: Nestlé Accused of Adding Sugar and Honey to Infant Formula and Breakfast Cereals in Low-Income CountriesApril 18, 2024
Empowering India's Youth: IG Drones & AASSC Launch Drone Skill Program, to Upskill 10M YouthApril 17, 2024
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment TechnologyApril 17, 2024
Top 5 online learning platform for learnersApril 17, 2024
Broad-Spectrum RNA Vaccine Breakthrough for Enhanced Virus ProtectionApril 17, 2024
The Impact of Excessive Internet Usage on School Absence: Finnish Study Reveals Key FindingsApril 17, 2024
Uncovering Delhi's Illegal Fertility Centre Operations: Insights from Recent Child Trafficking CasesApril 17, 2024
CarDekho's CSR Arm Girnar Foundation Hosts Health Check-up Camps for Underprivileged Children in Jaipur and GurugramApril 16, 2024
Atal Incubation Centre – Centre for Cellular and Molecular Biology (AIC-CCMB) signs agreement for placement of equipment with Thermo Fisher Scientific to help advance innovation in India April 16, 2024
AVEKSHA, four-day care centres, for the kids of industrial workers inauguratedApril 16, 2024
Nearly a third of the constituencies have zero women candidates in Phase 1 and 2 of LS Elections; reveals The Quantum Hub’s Factsheet April 16, 2024
Emergency Healthcare Provider Medulance Secures $3 Million Series A Funding Led by Alkemi Growth CapitalApril 16, 2024
The Healing Power of Natural Diversity: How Nature Boosts Mental HealthApril 16, 2024
Unveiling Cellular Recycling: How Nutrient-Starved Cells Adapt to Stressful ConditionsApril 16, 2024
Advancing Cancer Care: AIIMS Bhopal’s Workshop on Biomarker Interpretation in Breast CancerApril 15, 2024
10 Powerful Benefits to Diversify Healthcare Advertising ChannelsApril 15, 2024
Understanding Hospital Sink Contamination: Challenges in Fighting Multidrug-Resistant BacteriaApril 15, 2024
Rajasthan’s Swine Flu Situation: Health Department Observes DeclineApril 15, 2024
Is Your Doctor’s Prescription Incomplete ? Insights from Recent ICMR Study Suggests So!April 13, 2024